Global Orexin Receptor Type 2 Market Data Survey Report 2025

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 Actelion Pharmaceuticals Ltd

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Eisai Co Ltd

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Evotec AG

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Heptares Therapeutics Ltd

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Idorsia Ltd

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Johnson & Johnson

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Johnson & Johnson

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 OptiNose US Inc

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.9 Yangtze River Pharmaceutical Group

3.9.1 Company Information

3.9.2 Product Specifications

3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

4.1 Insomnia

4.1.1 Overview

4.1.2 Insomnia Market Size and Forecast

4.2 Narcolepsy

4.2.1 Overview

4.2.2 Narcolepsy Market Size and Forecast

4.3 Sleep Disorders

4.3.1 Overview

4.3.2 Sleep Disorders Market Size and Forecast

4.4 Major Depressive Disorder

4.4.1 Overview

4.4.2 Major Depressive Disorder Market Size and Forecast

5 Market by Type

5.1 HTL-6641

5.1.1 Overview

5.1.2 HTL-6641 Market Size and Forecast

5.2 MK-8133

5.2.1 Overview

5.2.2 MK-8133 Market Size and Forecast

5.3 Lemborexant

5.3.1 Overview

5.3.2 Lemborexant Market Size and Forecast

5.4 OPN-021

5.4.1 Overview

5.4.2 OPN-021 Market Size and Forecast

5.5 YNT-185

5.5.1 Overview

5.5.2 YNT-185 Market Size and Forecast

5.6 YNT-185

5.6.1 Overview

5.6.2 YNT-185 Market Size and Forecast

6 Conclusion

Tab Regional Production 2012-2017 (Volume)

Tab Regional Demand and CAGR 2012-2017 (Million USD)

Tab Regional Demand and CAGR 2012-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of Actelion Pharmaceuticals Ltd

Tab Sales Revenue, Volume, Price, Cost and Margin of Eisai Co Ltd

Tab Sales Revenue, Volume, Price, Cost and Margin of Evotec AG

Tab Sales Revenue, Volume, Price, Cost and Margin of Heptares Therapeutics Ltd

Tab Sales Revenue, Volume, Price, Cost and Margin of Idorsia Ltd

Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson

Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson

Tab Sales Revenue, Volume, Price, Cost and Margin of OptiNose US Inc

Tab Sales Revenue, Volume, Price, Cost and Margin of Yangtze River Pharmaceutical Group